Value20202021202220232024TTMSelling/general/admin expenses18.2 M9.39 M6.3 M4.66 M4.71 M4.83 MResearch & development9.53 M28.27 M31.54 M32.85 M37.76 M29.86 MOperating income18.28 M25.08 M34.49 M37.51 M42.47 M34.68 MNon-Operating Income, Total5.45 M376 K902 K13.2 M3.91 M5.64 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses4.95 M244 K781 K12.31 M3.48 M4.15 MUnusual income/expense503 K132 K121 K883 K432 K1.49 MPretax income12.83 M25.46 M33.59 M24.31 M38.56 M29.04 MEquity in earnings——————Taxes1.61 M8.04 M688 K244 K32 K132 KNon-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations11.22 M17.41 M32.9 M24.56 M38.53 M29.16 MDiscontinued operations——————Net income11.22 M17.41 M32.9 M24.56 M38.53 M29.16 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders11.22 M17.41 M32.9 M24.56 M38.53 M29.16 MBasic earnings per share (Basic EPS)-0.36-0.58-1.08-0.81-1.26-0.96Diluted earnings per share (Diluted EPS)-0.36-0.58-1.08-0.81-1.260.96Average basic shares outstanding30.82 M30.04 M30.44 M30.44 M30.46 M121.92 MDiluted shares outstanding30.82 M30.04 M30.44 M30.44 M30.46 M121.92 MEBITDA-16.08 M-22.48 M-31.9 M-35.81 M——EBIT-18.28 M-25.08 M-34.5 M-37.51 M——Cost of revenue34.55 M5.82 M651 K0——Other cost of goods sold——————Depreciation & amortization (cash flow)2.2 M2.6 M2.6 M1.7 M1.7 M1.7 M
XBiotech Inc
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.